{"id":{"repo_id":"qu-belfast","oai_identifier":"oai:pure.qub.ac.uk/portal:studenttheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e"},"canonical_url":"https://search.dev.ndltd.org/etd/qu-belfast/oai:pure.qub.ac.uk/portal:studenttheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e","repository":{"repo_id":"qu-belfast","name":"Queen's University Belfast","base_url":"https://pureadmin.qub.ac.uk/ws/oai"},"display":{"title":"The discovery and functional study of a bioactive peptide, QUB-3000, from the defensive skin secretion of the northern leopard frog, Rana pipiens","abstract":"To solve the drug-resistant microorganism problem, antimicrobial peptides (AMPs) have been studied as alternatives for traditional antibiotics. AMPs can inhibit and kill gram-negative bacteria, gram-positive bacteria, fungi and even cancer cells. Compared with traditional antibiotics, it is much more difficult for pathogens to develop drug-resistance towards AMPs, which is because of the distinct mechanisms of action of AMPs. <br/>In this study, an AMP precursor encoded by a cDNA was isolated and identified from the lyophilised skin secretion of the northern leopard frog, Rana pipiens, by “shotgun” cloning. According to its molecular mass, the mature peptide was named QUB-3000. Then, QUB-3000 was synthesised by solid phase peptide synthesis (SPPS), purified by RP-HPLC. The purified synthetic QUB-3000 was then subjected to several functional experiments analysis.<br/>QUB-3000 exhibited strong antimicrobial ability against the Gram-positive bacterium Staphylococcus aureus and the Gram-negative bacterium Escherichia coli. The minimum inhibitory concentration (MIC) values and minimum bactericidal concentration (MBC) values were 16 μM and 8 μM, respectively. While QUB-3000 possessed weak antimicrobial ability against the fungus Candida albicans with the MIC value at 256 μM and no MBC value. At the same time, QUB-3000 showed low haemolytic activity on horse blood cells. However, the 10-5 M QUB-3000 had very weak effects in inhibiting the growth of cancer cells (H-157, PC-3, U251MG), and it even could promote the growth of certain cancer cells (MCF-7). In the future, more functional investigations can be performed to develop QUB-3000 into a clinical drug. For example, circular dichroism (CD) can be used to confirm the secondary structure of QUB-3000. Furthermore, more drug-resistant bacteria can be used for assessing the antimicrobial activity of QUB-3000.<br/>","abstract_html":"To solve the drug-resistant microorganism problem, antimicrobial peptides (AMPs) have been studied as alternatives for traditional antibiotics. AMPs can inhibit and kill gram-negative bacteria, gram-positive bacteria, fungi and even cancer cells. Compared with traditional antibiotics, it is much more difficult for pathogens to develop drug-resistance towards AMPs, which is because of the distinct mechanisms of action of AMPs. &lt;br/&gt;In this study, an AMP precursor encoded by a cDNA was isolated and identified from the lyophilised skin secretion of the northern leopard frog, Rana pipiens, by “shotgun” cloning. According to its molecular mass, the mature peptide was named QUB-3000. Then, QUB-3000 was synthesised by solid phase peptide synthesis (SPPS), purified by RP-HPLC. The purified synthetic QUB-3000 was then subjected to several functional experiments analysis.&lt;br/&gt;QUB-3000 exhibited strong antimicrobial ability against the Gram-positive bacterium Staphylococcus aureus and the Gram-negative bacterium Escherichia coli. The minimum inhibitory concentration (MIC) values and minimum bactericidal concentration (MBC) values were 16 μM and 8 μM, respectively. While QUB-3000 possessed weak antimicrobial ability against the fungus Candida albicans with the MIC value at 256 μM and no MBC value. At the same time, QUB-3000 showed low haemolytic activity on horse blood cells. However, the 10-5 M QUB-3000 had very weak effects in inhibiting the growth of cancer cells (H-157, PC-3, U251MG), and it even could promote the growth of certain cancer cells (MCF-7). In the future, more functional investigations can be performed to develop QUB-3000 into a clinical drug. For example, circular dichroism (CD) can be used to confirm the secondary structure of QUB-3000. Furthermore, more drug-resistant bacteria can be used for assessing the antimicrobial activity of QUB-3000.&lt;br/&gt;","abstract_has_math":false,"creators":["Xu, Wei"],"institution":"Queen's University Belfast","degree_name":"Master of Philosophy","degree_level":"Masters Thesis","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Chen, Tianbao","Shaw, Christopher","Wang, Lei","Zhou, Mei"],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018-7","date_published":"2018-7","updated_at":"2026-07-24T03:54:53Z","subjects":[],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["oai:pure.qub.ac.uk/portal:studenttheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e"],"render_values":[{"text":"oai:pure.qub.ac.uk/portal:studenttheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e","href":null,"code":true}]}]},"links":{"outbound_url":"https://pure.qub.ac.uk/en/studentTheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Chen, Tianbao","Shaw, Christopher","Wang, Lei","Zhou, Mei"]},{"key":"dc:creator","label":"Author","values":["Xu, Wei"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2018-7"]},{"key":"dc:date.issued","label":"Date","values":["2018-7"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["School of Pharmacy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["Queen's University Belfast"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://pure.qub.ac.uk/en/studentTheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["Masters Thesis"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["Master of Philosophy"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights.embargodate","label":"Dc Rights Embargodate","values":["2024-02-29"]},{"key":"dc:rights.embargoreason","label":"Dc Rights Embargoreason","values":["/dk/atira/pure/core/document/studentthesisembargoreason/publicationissues"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["oai:pure.qub.ac.uk/portal:studenttheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e","https://pure.qub.ac.uk/en/studentTheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://pure.qub.ac.uk/files/157554216/Wei_Xu_Thesis.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["To solve the drug-resistant microorganism problem, antimicrobial peptides (AMPs) have been studied as alternatives for traditional antibiotics. AMPs can inhibit and kill gram-negative bacteria, gram-positive bacteria, fungi and even cancer cells. Compared with traditional antibiotics, it is much more difficult for pathogens to develop drug-resistance towards AMPs, which is because of the distinct mechanisms of action of AMPs. <br/>In this study, an AMP precursor encoded by a cDNA was isolated and identified from the lyophilised skin secretion of the northern leopard frog, Rana pipiens, by “shotgun” cloning. According to its molecular mass, the mature peptide was named QUB-3000. Then, QUB-3000 was synthesised by solid phase peptide synthesis (SPPS), purified by RP-HPLC. The purified synthetic QUB-3000 was then subjected to several functional experiments analysis.<br/>QUB-3000 exhibited strong antimicrobial ability against the Gram-positive bacterium Staphylococcus aureus and the Gram-negative bacterium Escherichia coli. The minimum inhibitory concentration (MIC) values and minimum bactericidal concentration (MBC) values were 16 μM and 8 μM, respectively. While QUB-3000 possessed weak antimicrobial ability against the fungus Candida albicans with the MIC value at 256 μM and no MBC value. At the same time, QUB-3000 showed low haemolytic activity on horse blood cells. However, the 10-5 M QUB-3000 had very weak effects in inhibiting the growth of cancer cells (H-157, PC-3, U251MG), and it even could promote the growth of certain cancer cells (MCF-7). In the future, more functional investigations can be performed to develop QUB-3000 into a clinical drug. For example, circular dichroism (CD) can be used to confirm the secondary structure of QUB-3000. Furthermore, more drug-resistant bacteria can be used for assessing the antimicrobial activity of QUB-3000.<br/>"]},{"key":"dc:title","label":"Title","values":["The discovery and functional study of a bioactive peptide, QUB-3000, from the defensive skin secretion of the northern leopard frog, Rana pipiens"]}]}],"canonical_facts":{"dc:contributor.advisor":["Chen, Tianbao","Shaw, Christopher","Wang, Lei","Zhou, Mei"],"dc:creator":["Xu, Wei"],"dc:date":["2018-7"],"dc:date.issued":["2018-7"],"dc:description.abstract":["To solve the drug-resistant microorganism problem, antimicrobial peptides (AMPs) have been studied as alternatives for traditional antibiotics. AMPs can inhibit and kill gram-negative bacteria, gram-positive bacteria, fungi and even cancer cells. Compared with traditional antibiotics, it is much more difficult for pathogens to develop drug-resistance towards AMPs, which is because of the distinct mechanisms of action of AMPs. <br/>In this study, an AMP precursor encoded by a cDNA was isolated and identified from the lyophilised skin secretion of the northern leopard frog, Rana pipiens, by “shotgun” cloning. According to its molecular mass, the mature peptide was named QUB-3000. Then, QUB-3000 was synthesised by solid phase peptide synthesis (SPPS), purified by RP-HPLC. The purified synthetic QUB-3000 was then subjected to several functional experiments analysis.<br/>QUB-3000 exhibited strong antimicrobial ability against the Gram-positive bacterium Staphylococcus aureus and the Gram-negative bacterium Escherichia coli. The minimum inhibitory concentration (MIC) values and minimum bactericidal concentration (MBC) values were 16 μM and 8 μM, respectively. While QUB-3000 possessed weak antimicrobial ability against the fungus Candida albicans with the MIC value at 256 μM and no MBC value. At the same time, QUB-3000 showed low haemolytic activity on horse blood cells. However, the 10-5 M QUB-3000 had very weak effects in inhibiting the growth of cancer cells (H-157, PC-3, U251MG), and it even could promote the growth of certain cancer cells (MCF-7). In the future, more functional investigations can be performed to develop QUB-3000 into a clinical drug. For example, circular dichroism (CD) can be used to confirm the secondary structure of QUB-3000. Furthermore, more drug-resistant bacteria can be used for assessing the antimicrobial activity of QUB-3000.<br/>"],"dc:identifier":["oai:pure.qub.ac.uk/portal:studenttheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e","https://pure.qub.ac.uk/en/studentTheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e"],"dc:identifier.uri":["https://pure.qub.ac.uk/files/157554216/Wei_Xu_Thesis.pdf"],"dc:language":["eng"],"dc:publisher.department":["School of Pharmacy"],"dc:publisher.institution":["Queen's University Belfast"],"dc:relation.isreferencedby":["https://pure.qub.ac.uk/en/studentTheses/85bce33d-e5e1-4ad2-9fda-cbbb5ca91d2e"],"dc:rights.embargodate":["2024-02-29"],"dc:rights.embargoreason":["/dk/atira/pure/core/document/studentthesisembargoreason/publicationissues"],"dc:title":["The discovery and functional study of a bioactive peptide, QUB-3000, from the defensive skin secretion of the northern leopard frog, Rana pipiens"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["Masters Thesis"],"dc:type.qualificationname":["Master of Philosophy"]},"updated_at":"2026-07-24T03:54:53Z"}